Klin Padiatr 2018; 230(03): 170
DOI: 10.1055/s-0038-1645007
Top 3 Solid tumors
Georg Thieme Verlag KG Stuttgart · New York

The role of BCORL1 in hepatoblastoma

T Krause
1   Department of Pediatric Surgery, University of Munich
,
S Sigl
1   Department of Pediatric Surgery, University of Munich
,
A Beck
1   Department of Pediatric Surgery, University of Munich
,
D von Schweinitz
1   Department of Pediatric Surgery, University of Munich
,
R Kappler
1   Department of Pediatric Surgery, University of Munich
› Author Affiliations
Further Information

Publication History

Publication Date:
08 May 2018 (online)

 
 

    Introduction:

    Genetically, HB is a very simple tumor with only 3 mutations per tumor and somatic β-catenin mutations representing the only recurrent alteration found so far. Instead, epigenetic alterations might play a role in the development and progression of this pediatric liver tumor.

    Methods:

    Mutations were detected by exome and Sanger sequencing. BCORL1 knockout cells were obtained by CRISPR-Cas9 technology. Proliferation was analyzed by MTT assay, expression by real-time PCR and RNA-seq, and histone modifications by ChIP-seq. Bioinformatic analysis was done with DNAstar software, DAVID and GSEA.

    Results:

    Four out of 79 HB harbored mutations in the BCL6 corepressor like 1 (BCORL1) gene. BCORL1 knockout cells showed a 3-dimensional growth pattern with decreased proliferation rates, which was associated with altered expression of genes associated with adhesion and translation and changes of H3K4me3 marks at candidate loci.

    Conclusion:

    BCORL1 is an important regulator of gene expression and mutated in a subset of HB.


    #